banner add

FDA Issues Warning of Cancer Risk Tied to CAR-T Therapies

The agency has reviewed reports of cancer patients whose treatments resulted in the development of secondary blood cancers. Several companies will be required to carry the new warning.

from NYT > Health https://ift.tt/z1xa53B
via IFTTT

No comments

CVS to Split Off Drugstore Business, Ending Its Bigger-Is-Better Era

In a breakup planned for 2028, CVS Health intends to keep together its insurance and pharmacy benefits divisions and create a separate compa...

Theme images by PLAINVIEW. Powered by Blogger.